newsfilter
← Latest News
PR Newswire·

Scinai Regains Full Compliance with Nasdaq Listing Requirements

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and...